Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1994 1
1997 1
2001 2
2003 2
2005 2
2006 4
2007 3
2008 2
2009 4
2010 2
2011 6
2012 5
2013 5
2014 8
2015 11
2016 13
2017 4
2018 4
2019 7
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Results by year
Filters applied: . Clear all
Page 1
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Ziganshina LE, Titarenko AF, Davies GR. Ziganshina LE, et al. Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD004795. doi: 10.1002/14651858.CD004795.pub4. Cochrane Database Syst Rev. 2013. PMID: 23744519 Free PMC article. Review.
Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients.
Jawahar MS, Banurekha VV, Paramasivan CN, Rahman F, Ramachandran R, Venkatesan P, Balasubramanian R, Selvakumar N, Ponnuraja C, Iliayas AS, Gangadevi NP, Raman B, Baskaran D, Kumar SR, Kumar MM, Mohan V, Ganapathy S, Kumar V, Shanmugam G, Charles N, Sakthivel MR, Jagannath K, Chandrasekar C, Parthasarathy RT, Narayanan PR. Jawahar MS, et al. PLoS One. 2013 Jul 3;8(7):e67030. doi: 10.1371/journal.pone.0067030. Print 2013. PLoS One. 2013. PMID: 23843980 Free PMC article. Clinical Trial.
Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.
Velayutham BV, Allaudeen IS, Sivaramakrishnan GN, Perumal V, Nair D, Chinnaiyan P, Paramasivam PK, Dhanaraj B, Santhanakrishnan RK, Navaneethapandian GP, Marimuthu MK, Kumar V, Kandasamy C, Dharuman K, Elangovan T, Narasimhan M, Rathinam S, Vadivelu G, Rathinam P, Chockalingam C, Jayabal L, Swaminathan S, Shaheed JM. Velayutham BV, et al. Clin Infect Dis. 2014 Nov 15;59(10):e142-9. doi: 10.1093/cid/ciu550. Epub 2014 Jul 14. Clin Infect Dis. 2014. PMID: 25028463 Clinical Trial.
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, Pappas F, Phillips PP, Nunn AJ; REMoxTB Consortium. Gillespie SH, et al. N Engl J Med. 2014 Oct 23;371(17):1577-87. doi: 10.1056/NEJMoa1407426. Epub 2014 Sep 7. N Engl J Med. 2014. PMID: 25196020 Free PMC article. Clinical Trial.
Fluoroquinolones for the treatment of pulmonary tuberculosis.
Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F. Moadebi S, et al. Drugs. 2007;67(14):2077-99. doi: 10.2165/00003495-200767140-00007. Drugs. 2007. PMID: 17883288 Review.
A four-month gatifloxacin-containing regimen for treating tuberculosis.
Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, Odhiambo J, Amukoye E, Bah B, Kassa F, N'Diaye A, Rustomjee R, de Jong BC, Horton J, Perronne C, Sismanidis C, Lapujade O, Olliaro PL, Lienhardt C; OFLOTUB/Gatifloxacin for Tuberculosis Project. Merle CS, et al. N Engl J Med. 2014 Oct 23;371(17):1588-98. doi: 10.1056/NEJMoa1315817. N Engl J Med. 2014. PMID: 25337748 Free article. Clinical Trial.
85 results
Jump to page
Feedback